Login to Your Account



Pharma: Clinic Roundup


Thursday, May 23, 2013

• Upsher-Smith Laboratories Inc., of Maple Grove, Minn., completed a global Phase III trial for USL255 (extended-release topiramate), an internally developed program for the management of epilepsy in adults.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription